Beckman Coulter’s Immunoassay Analyzer Extends Menu with Hepatitis Assays
Beckman Coulter expanded the menu of assays for its DxI 9000 Access Immunoassay Analyzer with the recent CE marking of hepatitis tests.
Read MorePosted by Andy Lundin | Apr 19, 2024 | Immunoassay Instrumentation |
Beckman Coulter expanded the menu of assays for its DxI 9000 Access Immunoassay Analyzer with the recent CE marking of hepatitis tests.
Read MorePosted by Andy Lundin | Apr 18, 2024 | Cancer |
Unilabs will use the SOPHiA DDM Platform to test for Homologous Recombination Deficiency in solid tumors, particularly in ovarian cancer.
Read MorePosted by Chris Wolski | Apr 17, 2024 | Womens Health |
Clinicians can now use two new biomarker-based assays in combination to determine which patients are at higher risk for poor outcomes.
Read MorePosted by Andy Lundin | Apr 17, 2024 | Infectious Diseases |
Delve Bio announced data on the use of mNGS for the definitive diagnosis of infectious causes of meningitis and/or encephalitis.
Read MorePosted by Andy Lundin | Apr 12, 2024 | Emerging & Zoonotic Diseases |
The FDA granted EUA for Labcorp’s Mpox PCR Test Home Collection Kit, facilitating the early detection and management of mpox infections.
Read More